HepaHope is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Rehab Medical is a mobility equipment provider that specializes in Complex Rehab Technology (CRT). CRT is the configuration of mobility equipment that requires custom fitting, design, adjustment, and programming to meet the unique needs of each patient. Rehab Medical strives to improve lives through CRT with its team of experienced assistive technology professionals (ATPs) who utilize innovative technology to help patients regain their independence. Since the company was founded in 2005, Rehab Medical has helped more than 100,000 people regain their independence through wheelchairs and has emerged as a national leader of complex rehab technology within the United States.
NOWDiagnostics Inc., based in Springdale, Ark., is a leader in innovative diagnostics testing. Its ADEXUSDx™ product line features a lab at your fingertip, using only a single drop of blood to test for a variety of common conditions, illnesses and diseases with results in a matter of minutes. By eliminating the need to send tests to off-site laboratories, NOWDiagnostics has the potential to decrease by days the waiting period to determine test results. The company is currently offering an hCG (pregnancy) test in the United States and Europe, and two cardiac (heart attack) tests and three toxicology tests in Europe. Additional tests are in the development pipeline, including sexually transmitted diseases, more cardiac (heart attack), food intolerances, common infectious diseases and a variety of screening tests.
HeartFlow is a medical technology company transforming the way cardiovascular disease is diagnosed and treated. With our HeartFlow Analysis, a non-invasive personalized cardiac test, physicians are able to make better care decisions for their patients with suspected coronary artery disease--the number one killer of men and women worldwide. HeartFlow is backed by decades of scientific research and development and leverages the latest advancements in technology to help set a new standard of care for diagnosing cardiovascular care worldwide. Cleared for use in the United States, Canada, Europe and Japan and with offices in Redwood City, Austin, London and Japan, HeartFlow`s footprint is growing rapidly. HeartFlow has received more than $240 million dollars in funding in a recent Series E financing round, is pre-IPO and leverages the latest technology including deep learning and computational fluid dynamics. We try to embody the best of both technology and healthcare companies and hire people who are passionate about living our mission to save lives, improve the patient experience and reduce the overall cost of care.
Hantel Technologies is a Hayward, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.